Novo Nordisk to slash Wegovy prices by 50%, Ozempic by 35%

February 24, 2026

TL;DR

Novo Nordisk plans to cut prices for Wegovy and Ozempic by up to 50% starting January 2027.
Wegovy will see a 50% price reduction, and Ozempic a 35% reduction.
Rybelsus, a type 2 diabetes pill sometimes used for weight loss, will also be offered at a reduced price.
The price cuts are attributed to growing competition in the weight-loss drug market, including from Eli Lilly's Mounjaro and Zepbound.
The decision aims to improve affordability and lower out-of-pocket costs for customers with high-deductible insurance plans.
Novo Nordisk previously announced a new pricing plan for Wegovy and Ozempic in November.
The price cuts will not affect 'direct-to-patient' prices.

Continue reading the original article